Level D· Scientific groundwork from lab and animal studiesLaboratory StudyEurope PMCOpen access

Epigenetic Dysregulation of the Homeobox A5 ( HOXA5 ) Gene Associates with Subcutaneous Adipocyte Hypertrophy in Human Obesity

Parrillo L., Spinelli R., Costanzo M., Florese P., Cabaro S., Desiderio A.

Laboratory Study on Type 2 Diabetes, published in Cells (2022) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Laboratory Study
Journal
Cells (2022)
Reported sample size
—
Source database
Europe PMC
PMID
35203377
PMCID
PMC8870634
DOI
10.3390/cells11040728
Citations
13

Abstract (original English)

Along with insulin resistance and increased risk of type 2 diabetes (T2D), lean first-degree relatives of T2D subjects (FDR) feature impaired adipogenesis in subcutaneous adipose tissue (SAT) and subcutaneous adipocyte hypertrophy well before diabetes onset. The molecular mechanisms linking these events have only partially been clarified. In the present report, we show that silencing of the transcription factor Homeobox A5 ( HOXA5 ) in human preadipocytes impaired differentiation in mature adipose cells in vitro. The reduced adipogenesis was accompanied by inappropriate WNT -signaling activation. Importantly, in preadipocytes from FDR individuals, HOXA5 expression was attenuated, with hypermethylation of the HOXA5 promoter region found responsible for its downregulation, as revealed by luciferase assay. Both HOXA5 gene expression and DNA methylation were significantly correlated with SAT adipose cell hypertrophy in FDR, whose increased adipocyte size marks impaired adipogenesis. In preadipocytes from FDR, the low HOXA5 expression negatively correlated with enhanced transcription of the WNT signaling downstream genes NFATC1 and WNT2B . In silico evidence indicated that NFATC1 and WNT2B were directly controlled by HOXA5 . The HOXA5 promoter region also was hypermethylated in peripheral blood leukocytes from these same FDR individuals, which was further revealed in peripheral bloo

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
AdipocytesHumansDiabetes Mellitus, Type 2ObesityHypertrophyHomeodomain ProteinsTranscription FactorsEpigenesis, GeneticGenes, Homeobox

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research